We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$499M
AUM Growth
+$4.35M
Cap. Flow
-$7.39M
Cap. Flow %
-1.48%
Top 10 Hldgs %
24.94%
Holding
248
New
15
Increased
55
Reduced
102
Closed
20

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.33M
2
MMM icon
3M
MMM
+$4.77M
3
LULU icon
lululemon athletica
LULU
+$4.74M
4
EL icon
Estee Lauder
EL
+$4.6M
5
BLK icon
Blackrock
BLK
+$3.29M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$6.38M
2
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
+$4.68M
3
ADSK icon
Autodesk
ADSK
+$2.48M
4
KSU
Kansas City Southern
KSU
+$2.33M
5
UPS icon
United Parcel Service
UPS
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 19.5%
2 Technology 18.93%
3 Financials 12.55%
4 Consumer Discretionary 10.74%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.46T
$18M 3.6%
938,308
+12,768
+1% +$243K
QCOM icon
2
Qualcomm
QCOM
$159B
$15.7M 3.14%
198,490
-5,745
-3% -$433K
EBAY icon
3
eBay
EBAY
$47.7B
$13.6M 2.73%
586,140
+72,059
+14% +$1.67M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.56T
$12.6M 2.53%
455,220
+402
+0.1% +$11.7K
BLK icon
5
Blackrock
BLK
$175B
$12.6M 2.52%
39,947
+10,748
+37% +$3.29M
GILD icon
6
Gilead Sciences
GILD
$162B
$12.1M 2.43%
171,225
-1,486
-0.9% -$117K
AKAM icon
7
Akamai
AKAM
$17.2B
$11.5M 2.3%
197,478
-10,290
-5% -$568K
CME icon
8
CME Group
CME
$95.7B
$10.3M 2.06%
139,091
+2,830
+2% +$213K
DEO icon
9
Diageo
DEO
$49.3B
$10.1M 2.01%
80,703
+5,088
+7% +$634K
TPR icon
10
Tapestry
TPR
$31.3B
$8.06M 1.62%
162,364
+8,320
+5% +$414K
EOG icon
11
EOG Resources
EOG
$77.4B
$8.02M 1.61%
81,798
-1,130
-1% -$101K
BMY icon
12
Bristol-Myers Squibb
BMY
$134B
$7.9M 1.58%
152,008
-17,762
-10% -$945K
ECL icon
13
Ecolab
ECL
$78.3B
$7.57M 1.52%
70,052
+3,465
+5% +$363K
COV
14
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$7.55M 1.51%
102,505
-1,260
-1% -$87.9K
AXP icon
15
American Express
AXP
$233B
$7.54M 1.51%
83,779
-4,275
-5% -$382K
LVS icon
16
Las Vegas Sands
LVS
$30.6B
$7.3M 1.46%
90,360
-16,720
-16% -$1.34M
SLB icon
17
SLB Ltd
SLB
$72.8B
$7.2M 1.44%
73,838
+435
+0.6% +$39.4K
DISCK
18
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$6.93M 1.39%
179,988
+77,540
+76% +$2.96M
HON icon
19
Honeywell
HON
$78.1B
$6.68M 1.34%
80,114
-2,387
-3% -$198K
ABBV icon
20
AbbVie
ABBV
$437B
$6.6M 1.32%
128,455
-95
-0.1% -$4.8K
HAR
21
DELISTED
Harman International Industries
HAR
$6.52M 1.31%
61,310
-4,100
-6% -$408K
TEVA icon
22
Teva Pharmaceuticals
TEVA
$40.1B
$6.09M 1.22%
+115,247
New +$5.33M
AFL icon
23
Aflac
AFL
$64.4B
$6.02M 1.21%
191,020
+1,380
+0.7% +$43.9K
DHR icon
24
Danaher
DHR
$139B
$5.85M 1.17%
116,085
+3,891
+3% +$198K
NKE icon
25
Nike
NKE
$63.4B
$5.67M 1.14%
153,478
-11,760
-7% -$444K
1
2 3 4 5

Similar funds

CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
EFS
Essex Financial Services Essex, Connecticut $1.78B AUM 23.37% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
OAM
Ostrum Asset Management Paris, France $1.78B AUM 27.8% 1-Year Est. Return

Franklin Street Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Franklin Street Advisors held 248 positions worth $499M, up 0.88% from $495M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Franklin Street Advisors's Q1 2014 filing shows 15 new, 55 increased, 102 reduced and 20 closed positions. Its largest new stake was Teva Pharmaceuticals: 115,247 shares worth $6.09M. The largest sale was Jazz Pharmaceuticals, an estimated $6.38M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q1 2014 buy was Teva Pharmaceuticals: 115,247 shares worth $6.09M.
  • Franklin Street Advisors added most to 3M in Q1 2014, an estimated $4.77M increase.
  • Franklin Street Advisors's biggest Q1 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $6.38M.
  • Franklin Street Advisors fully exited CAMERON INTERNATIONAL CORPORATION in Q1 2014, selling an estimated $4.68M.
  • Franklin Street Advisors's ten largest holdings make up 25% of its $499M portfolio in Q1 2014.
  • Franklin Street Advisors opened 15 new positions and closed 20 in Q1 2014.
  • Franklin Street Advisors's portfolio value rose 0.88% quarter-over-quarter to $499M.

Based on Franklin Street Advisors's 13F filing for Q1 2014, filed 4 Apr 2014.